Orchestra BioMed

CompanyUnited States

Orchestra BioMed develops one asset, in human trials (AVIM therapy in essential hypertension). Mostly device; based in the United States.

1
Asset
Furthest: Human trials; 1
Trial: 0
Signals

Pipeline

1

AVIM therapy
Atrioventricular interval modulation algorithm delivered via dual-chamber pacemaker to reduce blood pressure
Human trials, Device, essential hypertension, hypertension

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Similar companies6

Updated 7 Oct 2026 · 2 sources